General

Showing 1585–1600 of 2282 results

Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY
€3.03 Add to cart
Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life
€3.03 Add to cart
Article: P18 EVALUATION OF THE TAV8 (STAGO) AGGREGOMETER IN THE CLINICAL LABORATORY
€3.03 Add to cart
Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience
€3.03 Add to cart
Article: P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY
€3.03 Add to cart
Article: P19 Receptor tyrosine kinase AXL: a potential new target in multiple myeloma
€3.03 Add to cart
Article: P19 Vanishing bile duct syndrome associated with diffuse large B-cell lymphoma
€3.03 Add to cart
Article: P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients
€3.03 Add to cart
Article: P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€3.03 Add to cart
Article: P2.01 Functional evaluation of T cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system
€3.03 Add to cart
Article: P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria
€3.03 Add to cart
Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma
€3.03 Add to cart
Article: P2.03 Belgian Stop IMatinib trial
€3.03 Add to cart
Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€3.03 Add to cart
Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation
€3.03 Add to cart
Article: P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
€3.03 Add to cart

Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY

Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life

Article: P18 EVALUATION OF THE TAV8 (STAGO) AGGREGOMETER IN THE CLINICAL LABORATORY

Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience

Article: P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY

Article: P19 Receptor tyrosine kinase AXL: a potential new target in multiple myeloma

Article: P19 Vanishing bile duct syndrome associated with diffuse large B-cell lymphoma

Article: P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients

Article: P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

Article: P2.01 Functional evaluation of T cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system

Article: P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria

Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma

Article: P2.03 Belgian Stop IMatinib trial

Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation

Article: P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates